Search for: "Lupin Pharmaceuticals"
Results 141 - 160
of 175
Sorted by Relevance
|
Sort by Date
25 Nov 2009, 12:00 pm
US: Federal Circuit to hear oral argument in Ajinomoto v ITC 10 December (ITC Law Blog) US: Athena Diagnostics files suits against Ambry Genetics over alleged infringement of patents covering diagnostic technologies (Patent Docs) Products Dovonex (Calcipotriol) – UK: EWCA (Civ): Follow the instruction or lose the case - Sandoz's attempts at having finding of lack of anticipation overturned fails, appeal dismissed: Leo v Sandoz (IPKat) Famvir (Famciclovir) – US: New Jersey… [read post]
7 Sep 2011, 4:22 am
Apotex (Patently-O) Glivec (Imatinib mesylate) – India: The Glivec patent saga – its raining recusals (Spicy IP) Glivec (Imatinib mesylate) – India: Supreme Court to hear Novartis challenge to India’s patent law (IP Watch) Lo Loestrin Fe (Norethindrone acetate / Ethinyl estradiol / Ferrous fumarate) – US: Warner Chilcott files patent infringement complaint against Lupin in response to Para IV certification (Patent Docs) Lumigan (Bimatoprost) – US:… [read post]
25 Jan 2011, 10:58 pm
General GSK critiques Anti-Counterfeiting Trade Agreement (IP Watch) WHO Members show dismay at delay on Counterfeit Medicines Group (IP Watch) WHO R&D financing committee approved with controversial industry expert (IP Watch) (KEI) (KEI) (KEI) BioCentury this week explores orphan drugs with HP&M attorney and NORD Board Chair (FDA Law Blog) EU: Paediatric extensions and transitional provisions: a question of timing (The SPC Blog) India: Patent Office continue refusing pharmaceutical… [read post]
8 May 2009, 8:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Mircera (Methoxy polyethylene glycol-epoetin beta) – US: Federal Circuit revises Amgen v ITC (Patently-O) (Patent Baristas) (ITC 337 Law Blog) (Hal Wegner) (Patent Docs) General Alicia Greenidge to step down as Director of IFPMA (Intellectual Property Watch) Flu crisis could lead to compulsory licences (Managing… [read post]
15 Jul 2009, 5:15 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: European Commission Competition DG releases final report on pharmaceutical sector (IPKat) (PatLit) (BLOG@IP::JUR) (IAM) (Managing Intellectual Property) (Intellectual Property Watch) (The SPC Blog) (IAM) US: Follow-on biologics proposals considered by US Senate HELP Committee; Committee passes amendment for 12-year biologics exclusivity period… [read post]
3 Mar 2010, 5:05 am
(IP Osgoode) Australia: University of Western Australia’s application to appeal FCAFC’s decision in University of Western Australia v Gray fails (IP Whiteboard) Colombia/EU/Peru: Tough IP health provisions in Europe’s Colombia/Peru trade deal (IP Watch) (IP tango) EU: Something more about Swiss type claims: G02/08 (SiNApSE) (SiNApSE) US: Pharmaceutical patent settlements – and what about patients? [read post]
3 Mar 2010, 5:05 am
(IP Osgoode) Australia: University of Western Australia’s application to appeal FCAFC’s decision in University of Western Australia v Gray fails (IP Whiteboard) Colombia/EU/Peru: Tough IP health provisions in Europe’s Colombia/Peru trade deal (IP Watch) (IP tango) EU: Something more about Swiss type claims: G02/08 (SiNApSE) (SiNApSE) US: Pharmaceutical patent settlements – and what about patients? [read post]
17 Feb 2010, 5:10 am
King Pharmaceuticals Inc. et al (Patent Docs) Famvir (Famciclovir) – US: Teva and Novartis settle patent litigation regarding Famciclovir (IP Factor) (SmartBrief) Gardasil, Silgard - Portugal: More on Gardasil and Silgard from Portugal (SPC Blog) Lipitor (Atorvastatin) – Philippines: UniLab can still sell generic version of Pfizer's Lipitor after a Makati court denies latter's petition for preliminary injunction (GenericsWeb) Mucinex (Guaifenesin) – US: W D… [read post]
27 Jul 2011, 1:01 am
KG (TTABlog) US: ALJ Rogers sets 17-month target date in Certain Coenzyme Q10 Products (337-TA-790) (ITC 337 Law Blog) Products Alimta (Pemetrexed) – US: Eli Lilly files patent infringement complaints against APP Pharmaceuticals in Delaware and S D Indiana in response to Para IV certification filing (Patent Docs) Cenestin (Synthetic conjugated estrogens) – US: CAFC: Prosecution history estoppel bars Duramed’s allegations of infringement under doctrine of… [read post]
10 May 2010, 11:26 am
" Lupin challenged the PTO's granting an extension to 5,053,407, "an enantiomer of a racemic compound that had previously been approved by the Food and Drug Administration (FDA)," to no avail. [read post]
22 Feb 2012, 5:49 pm
Lupin, Ltd. et al. [read post]
7 Apr 2010, 4:30 am
Sandoz Pharmaceuticals GmbH et al (EPLAW) Prilosec (Omeprazole) – US: AstraZeneca ordered to pay attorney’s fees for ‘baseless’ suit to protect Prilosec OTC: AstraZeneca AB et al. v. [read post]
9 Feb 2009, 11:32 pm
(alleged infringers)Eli Lilly's (patent owner) Cymbalta drugAstraZeneca's (patent owner) Crestor drugPenwest Pharmaceuticals (patent owner) Opana ER drugSepracor's (patent owner) Xyzal drugOf Apple and US 7,479,949, see the IPBiz post Obvious? [read post]
12 Apr 2011, 10:07 pm
Infringement proceedings by the European Commission against Italy (Kluwer Patent Blog) India approves free access to important portions of the Traditional Knowledge Digital Library (TK Community) (Spicy IP) USPTO proposes changes to PTA and PTE provisions (Patent Docs) US: FDA issues warning letter for failure to submit animal study reports in an IDE (FDA Law Blog) US: AMP v USPTO – oral argument at the Federal Circuit (Patent Docs) US: A historical perspective on the gene patent controversy… [read post]
17 Nov 2011, 2:17 am
The winners were as follows: Copyright law firm of the year: Berwin Leighton Paisner Trade mark law firm of the year: Grau & Angulo Patent law firm of the year: Allen & Overy IP law firm of the year in an emerging market: Remfry & Sagar IP Law firm of the year: Allen & Overy Domain name/online strategy of the year: Kilpatrick Townsend & Stockton for the Namealizer, a domain name evaluation tool Outstanding IP portfolio management/development in… [read post]
3 Jan 2012, 8:15 am
And the fans of Arsène Lupin, the French ‘gentleman burglar’, are now able to borrow – for good! [read post]
17 Mar 2020, 1:32 pm
Eco-Gel 200 ultrasound gel has been recalled by Eco-Med Pharmaceutical, Inc. due to bacterial contamination. [read post]
29 Dec 2010, 2:57 am
Ferring Pharmaceuticals, Inc et al. [read post]
3 Jun 2010, 5:42 pm
Lupin Pharmaceuticals, Inc. [read post]
3 Aug 2011, 3:31 am
Patent and Trademark Office (Holman’s Biotech IP Blog) US: Myriad writes to CAFC on standing issue (Patent Docs) (Patent Docs) (Holman’s Biotech IP Blog) US: In the first 7 months of 2011, the FDA has approved 18 new molecular entity pharmaceutical drugs (and no biologic NMEs) (KEI) US: Embryonic stem cell funding suit dead: Sherley v. [read post]
